11 – 20 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
One-hour glucose value as a long-term predictor of cardiovascular morbidity and mortality : the Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016
(
- Contribution to journal › Article
-
Mark
Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma
(
- Contribution to journal › Article
-
Mark
Aggressive pituitary tumours and carcinomas : two sides of the same coin?
(
- Contribution to journal › Scientific review
-
Mark
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
(
- Contribution to journal › Article
-
Mark
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
(
- Contribution to journal › Article
- 2016
-
Mark
Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
(
- Contribution to journal › Article
-
Mark
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.
(
- Contribution to journal › Article